Business Wire

Home and Heart of global Toblerone Production: Mondelēz International invests ~65 million Swiss Francs (CHF) in its Toblerone manufacturing facility in Switzerland

10.4.2025 07:00:00 CEST | Business Wire | Press release

Share

Mondelēz International, one of the world’s largest snacking companies, is investing in its manufacturing facility in Bern (Switzerland), the home and heart of Toblerone. The significant investment in Bern will create the global center of excellence for Toblerone in Switzerland. With the investment in Bern, the company underlines Toblerone's growth ambitions to win in the premium segment.

Mondelēz International (Nasdaq: MDLZ) has today announced a significant investment of ~ 65 million swiss francs in its Toblerone manufacturing facility in Switzerland. With this investment, the company is creating a global centre of excellence for Toblerone in Bern (Switzerland)from where the brand and chocolate expertise is exported all over the world. The investment is a clear commitment to the location where this traditional brand was founded back in 1908 and where around 90 percent of Toblerone products sold worldwide are manufactured today. The investment in Bern underlines Toblerone's growth ambitions in the chocolate premium segment, building on its global awareness, uniqueness and leading position in world travel retail.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250409162507/en/

Toberlone Factory - Bern, Switzerland - Marco Blessano

A state-of-the-art production line scheduled to go into operation in autumn 2025 is about to be installed in our Bern manufacturing facility, to expand capacity following growing demand for premium chocolate. Alongside the new line, Mondelēz is also upscaling its chocolate and nougat making facility, upgrading the site infrastructure and logistics.

Thanks to this investment, Bern will become the “Center of Excellence” for Toblerone, from where the brand and its chocolate expertise is exported all over the world. It is one of the most important investments within Mondelēz International's chocolate European production network in the last 10 years.

As part of Mondelēz’s ambition to become the number one player in Chocolate by 2030, our iconic 117-year-old brand Toblerone is poised to grow globally within the premium segment, leveraging its strong global awareness, uniqueness, and leadership in World Travel Retail business.

The investment is both an expression of the traditional brand's growth ambitions and a clear commitment to Bern as the home and heart of the production, where Toblerone was founded in 1908 and where around 90 percent of its products sold worldwide are produced. As a testimony to this rich heritage, the Swiss flag will soon adorn the packaging of the Toblerone tablets that are manufactured in Bern – to emphasize where the chocolate is made.

“Toblerone is one of the most famous chocolate brands in the world with tremendous potential,” said Iain Livingston, President, Toblerone & World Travel Retail. “Our center of excellence in Switzerland, from where we proudly bring our brand and chocolate expertise around the world, is key to the brand's growth ambition to win in the premium segment.”

Tim Spickenbaum, Director of the production facility in Bern, adds: “Our plant has been a cornerstone of the Toblerone production for decades. Already today we manufacture on average 4 million Toblerone products per production day. We are therefore delighted about the planned modernizations and investments, which will not only enhance our manufacturing capacity but also solidify Bern's position as the home and heart of the triangular brand icon.”

Toblerone Fast Facts: Did You Know?

  • Toblerone was invented in Switzerland by Theodor Tobler and Emil Baumann in 1908.
  • “Toblerone” is a play on words from the names ‘Tobler’ and ‘Torrone’, the Italian name for honey-almond nougat. The special feature is the triangular shape of the tablet.
  • Since 1985, Toblerone has been produced at the factory in Bern, Switzerland, where today around 90 percent of Toblerone products sold worldwide are manufactured.

Further photos accompanying this announcementare available at:link.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250409162507/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Imagine Dragons to Perform at Abu Dhabi Grand Prix21.5.2026 17:51:00 CEST | Press release

Ethara, organiser of the Formula 1 Etihad Airways Abu Dhabi Grand Prix, have announced that one of the world’s biggest bands, Imagine Dragons, will headline the Saturday After-Race Concerts at the F1 Season Finale in Abu Dhabi. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521214839/en/ Imagine Dragons to perform at Formula 1 Etihad Airways Abu Dhabi Grand Prix (Photo: AETOSWire) The announcement is another landmark moment for the Abu Dhabi Grand Prix, whose thrilling Yasalam presented by e& fan entertainment offering has become synonymous with the F1 Championship finale in Abu Dhabi and is recognised as one of the most compelling sports and entertainment crossovers globally. The global chart-toppers join Lewis Capaldi and Zara Larsson, who are set to kick off a blockbuster line-up of performances on Yas Island on Thursday, 3 December, with more major international artists to be revealed. With their popular top hits, Ima

Carnegie Mellon University and Cleveland Clinic Develop AI System to Interpret Cardiac MRI Scans with Enhanced Accuracy21.5.2026 14:05:00 CEST | Press release

Trained on more than 13,000 patient studies, novel system significantly outperforms existing models by up to 35% A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521762286/en/ A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. The novel system, called CMR-CLIP, is d

Otovo Hits 30,000 Customers in Under a Year, Tackling the Growing ‘Solar Service Crisis’21.5.2026 14:00:00 CEST | Press release

A growing wave of unsupported solar systems and rising electricity prices are creating strong demand for Otovo’s energy service platform Otovo ASA (“Otovo”), a leading global energy service provider for residential and commercial customers, today announced it has reached 30,000 customers across the U.S. and Europe. A total of 20,000 customers have enrolled in Otovo Care, the Company’s membership-based home and commercial energy service, which is powered by Otovo’s industry-leading AI platform, Endurance™. “Reaching 30,000 customers in less than year is proof positive that home and business owners value their power systems,” said William J. (John) Berger, CEO of Otovo. “The ‘solar service crisis’ that is leaving millions of orphaned energy systems without support is driving strong interest in our Otovo Care membership program. Every day your home or commercial power system is not working, you are throwing money away. Otovo’s rapid response service platform keeps you up and running, ensu

The Live Moment Effect: Genius Sports and MediaScience Study Finds Specific Moments in Live Sports Can Double Unaided Brand Recall21.5.2026 14:00:00 CEST | Press release

New research shows that brands aligned with emotionally heightened moments in live sports can improve ad effectiveness Genius Sports Limited (NYSE: GENI), a global leader in real-time sports data, today released new biometric research conducted with MediaScience showing that ads delivered immediately after emotionally heightened moments in live sports can double unaided brand recall. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521475265/en/ The Live Moment Effect report from Genius Sports and MediaScience. The study, The Live Moment Effect, finds that advertising effectiveness is significantly influenced by a viewer’s emotional state immediately before an ad is shown. In controlled biometric testing, ads shown after high-intensity sporting moments, such as near-scoring plays or crucial momentum shifts, delivered approximately double the unaided brand recall of baseline conditions. The Moment Before the Ad Matters The r

Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer21.5.2026 14:00:00 CEST | Press release

Precemtabart tocentecan (Precem-TcT) is investigated as a potential first-in-class anti-CEACAM5 ADC, for the treatment of metastatic CRC (mCRC) CEACAM5 is overexpressed in the majority of colorectal tumors (~90%), and requires no patient selection Significant unmet need remains for clinically meaningful innovation in colorectal cancer (CRC), the second leading cause of cancer death worldwide Not intended for Canada-, UK- or US-based media Merck, a leading science and technology company, today announced that the first patient has been dosed in the Phase 3 PROCEADE®-CRC-03 trial (NCT07549412). The study is evaluating precemtabart tocentecan (Precem‑TcT), a potential first‑in‑class investigational anti‑CEACAM5 antibody‑drug conjugate (ADC), for the treatment of metastatic colorectal cancer (mCRC). “Leveraging our novel payload‑linker technology, Precem‑TcT is the first CEACAM5‑targeted ADC in clinical studies with an exatecan payload, rationally designed for stability and enhanced cancer

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye